홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite | Synapse
May 11, 2026
Open Access
Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite
TS
Tatsuyuki Sato
Jichi Medical University
TI
Takayuki Isagawa
Jichi Medical University
YS
Yuki Sugiura
See all
Key Points
Key points are not available for this paper at this time.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Sato et al. (Wed,) studied this question.
synapsesocial.com/papers/6a025f2bc9581ed855361d19
https://doi.org/https://doi.org/10.5167/uzh-433967